Colonna, Marco http://orcid.org/0000-0001-5222-4987
Article History
Accepted: 11 January 2023
First Online: 7 February 2023
Competing interests
: M.C. is a member of the Vigil Scientific Advisory Board and NGM Bio, is consultant for Cell Signalling Technology and has received research grants from Vigil, NGM Bio and Ono during the conduct of the study. In addition, M.C. has a patent related to TREM2 pending.
Free to read: This content has been made available to all.